OBSESSIVE COMPULSIVE DISORDER / OCD +

[mjhealthtips]

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. (abst - 2010) http/www.ncbi.nlm.nih.gov/pubmed/20695034 Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3034086/pdf/nihms262924.pdf Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ(9)-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessivecompulsive behaviour. (abst – 2011) http/www.ncbi.nlm.nih.gov/pubmed/21796370 Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug. (full – 2012) http/www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. (full – 2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/ Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22248639 Cannabidiol reverses the mCPP-induced increase in marble-burying behavior. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24118015 β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24930711 Paracetamol potentiates the antidepressant-like and anticompulsive-like effects of fluoxetine (abst – 2014)http://www.ncbi.nlm.nih.gov/pubmed/25340977